[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__Mitigation_325 

# __TCID50 assay__

## This Mitigation is enabled by the following technologies

* [human host cells](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3155.md)
* [infection medium](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3156.md)

## Closest similar item

* [Tissue culture infectious dose at the 50% endpoint (TCID50) technique](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_850.md)
* [Nested PCR assay](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1083.md)
* [Robust RT-qPCR assays](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_64.md)
* [Monitoring of Pharmaceuticals and Metabolites](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1924.md)
* [Nucleic acid testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1436.md)
* [Biomarker testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_513.md)
* [Biosensors for diagnostics](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1232.md)
* [Testing and early detection](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1092.md)
* [Infectious disease monitoring](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_4.md)
* [ASTM E1153 Method](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_854.md)

## Risks possibly mitigated by this Mitigation


## Property: has_MitigationPrinciple

The assay measures virus infectivity by assessing cytopathic effects in host cells after exposure to different doses of far-UVC light.

## Property: has_MitigationSource

* [Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_182.md)

